Reproducibility of Strength Testing and Functional Testing of the Hip for the Return to Sport of Patients Activated by a Femoroacetabular Impingement: Comparison Between a Group of Patients and a Group of Healthy Controls

Femoroacetabular Impingement Clinical Trial

— H-Repro  

Official title:

Reproducibility of Strength Testing and Functional Testing of the Hip for the Return to Sport of Patients Activated by a Femoroacetabular Impingement: Comparison Between a Group of Patients and a Group of Healthy Controls

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05391204
• Other study ID #: 2020-A01382-37
• Status: Recruiting
• Phase: N/A
• Start date: October 20, 2020
• Est. completion date: January 31, 2023

Study information

• Verified date: March 2022
• Source: Ramsay Générale de Santé
• Contact: JF ECTEN
• Phone: 0683346567
• Email: jf.oudet[@]ecten.eu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Reproducibility of strength testing and functional testing of the hip for the return to sport of patients activated by a femoroacetabular impingement: comparison between a group of patients and a group of healthy controls Femoroacetabular impingement is a disorder movement-related hip clinic, with bone abnormality at the joint coxo-femoral associated with a triad of symptoms, clinical signs and findings imagery. It represents premature contact symptomatic between the femur and the acetabulum. Currently, there is no consensus for determine when to return to sport securely after processing arthroscopy of a emoroacetabular impingement. Various clinical tests are used to assess the mobility or pain but no test studies specifically the level of recovery functional.

Description:

Reproducibility of strength testing and functional testing of the hip for the return to sport of patients activated by a femoroacetabular impingement: comparison between a group of patients and a group of healthy controls Femoroacetabular impingement is a disorder movement-related hip clinic, with bone abnormality at the joint coxo-femoral associated with a triad of symptoms, clinical signs and findings imagery. It represents premature contact symptomatic between the femur and the acetabulum. Currently, there is no consensus for determine when to return to sport securely after processing arthroscopy of a emoroacetabular impingement. Various clinical tests are used to assess the mobility or pain but no test studies specifically the level of recovery functional.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: January 31, 2023
• Est. primary completion date: January 31, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 16 Years to 50 Years

Eligibility

Inclusion Criteria:

Patients

• Male or female aged 16 to 50
• Occurrence of the injury requiring surgery during a sports activity
• Hip arthroscopy
• Surgery performed by surgeons from the Santy Orthopedic Center (Lyon)
• Angle Alpha > 55°
• Patient having signed an informed consent
• Affiliated subject or beneficiary of a social Security Control group
• Male or female aged 16 to 50
• Practicing a regular sporting activity In both groups
• Patient having signed an informed consent
• Affiliated subject or beneficiary of a social Security Exclusion Criteria: Patient group
• Contraindication of the surgeon
• Present another pathology of the hip on the side of the operated limb or on the contralateral side Control group
• Declare a history of lower limb pain/injury in the last 12 months
• Declare a history of orthopedic surgery on the lower limbs In any case will be excluded Protected subject: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision.

Related Conditions & MeSH terms

• Femoracetabular Impingement
• Femoroacetabular Impingement

Intervention

Other:
• Functional Tests
Various physical exercices of inferior members

Locations

Country	Name	City	State
France	Centre Santy	Lyon	Aura

Sponsors (2)

Lead Sponsor	Collaborator
Ramsay Générale de Santé	Ramsay santé

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Reproducibility rate	intra- and inter-session reproducibility	8 months